Technical Analysis for SILO - Silo Pharma, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
50 DMA Support | Bullish | -1.60% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -1.60% | |
Lower Bollinger Band Walk | Weakness | -1.60% | |
Gapped Down | Weakness | -1.60% | |
Lower Bollinger Band Touch | Weakness | -1.60% | |
200 DMA Support | Bullish | -1.60% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 9 hours ago |
10 DMA Resistance | about 11 hours ago |
Gap Down Closed | about 12 hours ago |
Reversed from Down | about 12 hours ago |
50 DMA Support | about 12 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Alzheimer's Disease Parkinson's Disease Depression Post Traumatic Stress Disorder Rare Neurological Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Alzheimer's Disease Parkinson's Disease Depression Post Traumatic Stress Disorder Rare Neurological Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.05 |
52 Week Low | 1.2162 |
Average Volume | 238,125 |
200-Day Moving Average | 1.71 |
50-Day Moving Average | 1.79 |
20-Day Moving Average | 1.95 |
10-Day Moving Average | 1.91 |
Average True Range | 0.17 |
RSI (14) | 47.09 |
ADX | 23.28 |
+DI | 13.91 |
-DI | 18.83 |
Chandelier Exit (Long, 3 ATRs) | 1.89 |
Chandelier Exit (Short, 3 ATRs) | 2.14 |
Upper Bollinger Bands | 2.12 |
Lower Bollinger Band | 1.79 |
Percent B (%b) | 0.19 |
BandWidth | 17.19 |
MACD Line | 0.02 |
MACD Signal Line | 0.05 |
MACD Histogram | -0.0279 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.11 | ||||
Resistance 3 (R3) | 2.11 | 2.02 | 2.06 | ||
Resistance 2 (R2) | 2.02 | 1.96 | 2.02 | 2.05 | |
Resistance 1 (R1) | 1.94 | 1.92 | 1.90 | 1.94 | 2.03 |
Pivot Point | 1.85 | 1.85 | 1.83 | 1.85 | 1.85 |
Support 1 (S1) | 1.77 | 1.79 | 1.73 | 1.77 | 1.67 |
Support 2 (S2) | 1.68 | 1.75 | 1.68 | 1.65 | |
Support 3 (S3) | 1.60 | 1.68 | 1.64 | ||
Support 4 (S4) | 1.60 |